Inventor · disambiguated record
Lee D. Arnold
Also filed as: ARNOLD LEE · ARNOLD LEE D · ARNOLD LEE DANIEL
64 granted patents·40 pending applications·3,325 citations·filing 1988–2025
99Inventor score
Files withPARDES BIOSCIENCES INC13ASSEMBLY BIOSCIENCES INC12KINNATE BIOPHARMA INC10ABBOTT GMBH & CO KG7PFIZER7
Top patents by PatentIndex Score
104 records- 0199US7534797B26,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitorsOSI PHARM INC·Filed 2005·Granted May 19, 2009·100 cites·9 claims
- 0299US5747498AAlkynyl and azido-substituted 4-anilinoquinazolinesPFIZER·Filed 1996·Granted May 5, 1998·1.2k cites·32 claims
- 0398US6921763B2Pyrazolopyrimidines as therapeutic agentsABBOTT LAB·Filed 2001·Granted Jul 26, 2005·275 cites·132 claims
- 0498US6660744B1Pyrazolopyrimidines as therapeutic agentsABBOTT GMBH & CO KG·Filed 2000·Granted Dec 9, 2003·331 cites·86 claims
- 0597US10927111B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2020·Granted Feb 23, 2021·9 cites·29 claims
- 0697US7332497B2Pyrazolopyrimidines as therapeutic agentsABBOTT GMBH & CO KG·Filed 2002·Granted Feb 19, 2008·217 cites·24 claims
- 0796US11174231B1Inhibitors of cysteine proteases and methods of use thereofPARDES BIOSCIENCES INC·Filed 2021·Granted Nov 16, 2021·36 cites·1 claims
- 0896US11124497B1Inhibitors of cysteine proteases and methods of use thereofPARDES BIOSCIENCES INC·Filed 2021·Granted Sep 21, 2021·57 cites·8 claims
- 0996US6130217ACompounds enhancing antitumor activity of other cytotoxic agentsPFIZER·Filed 1995·Granted Oct 10, 2000·181 cites·4 claims
- 1095US11345681B1Inhibitors of fibroblast growth factor receptor kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted May 31, 2022·4 cites·19 claims
- 1195US6225318B14-aminoquinazolone derivativesPFIZER·Filed 1999·Granted May 1, 2001·112 cites·6 claims
- 1294US6713474B2Pyrrolopyrimidines as therapeutic agentsABBOTT GMBH & CO KG·Filed 2000·Granted Mar 30, 2004·59 cites·70 claims
- 1394US5736534A4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agentsPFIZER·Filed 1995·Granted Apr 7, 1998·80 cites·20 claims
- 1493US10377748B2Hepatitis B core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2016·Granted Aug 13, 2019·6 cites·3 claims
- 1592US10392379B2Hepatitis B core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2016·Granted Aug 27, 2019·5 cites·16 claims
- 1692USRE41065EAlkynl and azido-substituted 4-anilinoquinazolinesPFIZER·Filed 2008·Granted Dec 29, 2009·19 cites·35 claims
- 1792US6001839ASubstituted 4-amino-7H-pyrrolo [2,3,-d]-pyrimidines as PTK inhibitorsBASF AG·Filed 1998·Granted Dec 14, 1999·144 cites·28 claims
- 1891US10894788B2Inhibitors of cyclin-dependent kinasesKINNATE BIOPHARMA INC·Filed 2019·Granted Jan 19, 2021·5 cites·29 claims
- 1991US7923555B2Fused bicyclic mTor inhibitorsOSI PHARM INC·Filed 2008·Granted Apr 12, 2011·15 cites·2 claims
- 2091US6395733B1Heterocyclic ring-fused pyrimidine derivativesPFIZER·Filed 1995·Granted May 28, 2002·74 cites·9 claims
- 2190US7049312B1Benzothiazinone and benzoxazinone compoundsABBOTT GMBH & CO KG·Filed 2000·Granted May 23, 2006·102 cites·10 claims
- 2290US6297238B1Therapeutic agentsBASF AG·Filed 2000·Granted Oct 2, 2001·65 cites·42 claims
- 2389US8314111B2Fused bicyclic motor inhibitorsCHEN XIN·Filed 2011·Granted Nov 20, 2012·12 cites·2 claims
- 2489US7820662B26,6-bicyclic ring substituted heterobicyclic protein kinase inhibitorsOSI PHARM INC·Filed 2008·Granted Oct 26, 2010·12 cites·19 claims
- 2588US11312704B2Inhibitors of cysteine proteases and methods of use thereofPARDES BIOSCIENCES INC·Filed 2021·Granted Apr 26, 2022·1 cites·7 claims
- 2688US7943767B2Fused bicyclic mTOR inhibitorsOSI PHARM INC·Filed 2009·Granted May 17, 2011·9 cites·14 claims
- 2787US8796455B2Fused bicyclic mTOR inhibitorsCHEN XIN·Filed 2013·Granted Aug 5, 2014·8 cites·10 claims
- 2887US8101613B26,6-bicyclic ring substituted heterobicyclic protein kinase inhibitorsARNOLD LEE D·Filed 2009·Granted Jan 24, 2012·10 cites·15 claims
- 2986US11667634B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted Jun 6, 2023·1 cites·8 claims
- 3085US7091227B2Benzothiazole derivativesABBOTT GMBH & CO KG·Filed 2001·Granted Aug 15, 2006·29 cites·40 claims
- 3185US6462036B1Tricyclic pyrazole derivativesBASF AG·Filed 2000·Granted Oct 8, 2002·38 cites·55 claims
- 3284US2024025890A1Hepatitis b core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3384US2024270721A1Inhibitors of cysteine proteases and methods of use thereofPARDES BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3482US9212151B2Heterocyclic compounds useful for kinase inhibitionAMITECH THERAPEUTIC SOLUTIONS INC·Filed 2015·Granted Dec 15, 2015·4 cites·21 claims
- 3582US2023192663A1Inhibitors of cysteine proteases and methods of use thereofPARDES BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3681US10183936B2Hepatitis B core protein allosteric modulatorsUNIV INDIANA RES & TECH CORP·Filed 2015·Granted Jan 22, 2019·3 cites·11 claims
- 3780US7863444B24-aminopyrrolopyrimidines as kinase inhibitorsABBOTT LAB·Filed 1999·Granted Jan 4, 2011·31 cites·11 claims
- 3879US12145911B2Inhibitors of cysteine proteases and methods of use thereofPARDES BIOSCIENCES INC·Filed 2022·Granted Nov 19, 2024·0 cites·4 claims
- 3979US11472793B2Inhibitors of cysteine proteases and methods of use thereofPARDES BIOSCIENCES INC·Filed 2022·Granted Oct 18, 2022·0 cites·4 claims
- 4079US2022402896A1Inhibitors of cysteine proteases and methods of use thereofPARDES BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4179US2022324844A1Inhibitors of cysteine proteases and methods of use thereofPARDES BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4278US6451834B1Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivativesBASF AG·Filed 2000·Granted Sep 17, 2002·14 cites·13 claims
- 4377US7468371B2Tricyclic pyrazole kinase inhibitorsABBOTT LAB·Filed 2005·Granted Dec 23, 2008·4 cites·20 claims
- 4476US11078170B2Cyclic sulfamide compounds and methods of using sameASSEMBLY BIOSCIENCES INC·Filed 2018·Granted Aug 3, 2021·1 cites·35 claims
- 4575US11814376B2Hepatitis b core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2021·Granted Nov 14, 2023·0 cites·6 claims
- 4675US8575164B2Combination cancer therapyARNOLD LEE D·Filed 2008·Granted Nov 5, 2013·1 cites·14 claims
- 4772US11524940B1Inhibitors of cysteine proteases and methods of use thereofPARDES BIOSCIENCES INC·Filed 2021·Granted Dec 13, 2022·0 cites·16 claims
- 4872US6413971B1Fused bicyclic pyrimidine derivativesPFIZER·Filed 1997·Granted Jul 2, 2002·34 cites·22 claims
- 4970US10968211B2Hepatitis B core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2019·Granted Apr 6, 2021·0 cites·12 claims
- 5070US8957216B2Heterocyclic compounds useful for kinase inhibitionARNOLD LEE DANIEL·Filed 2011·Granted Feb 17, 2015·2 cites·12 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →